Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001144204-10-036806

Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KESSEL MARK Director 2010-07-01 Grant or award +25,000 $0.38 $9,503 27,297,118 I
Loading xslF345X03/form433530_070610195152-.xml…